| Parameters |
ITT Population (N=394) n (%) |
|
Number of Patients
treated Bilaterally |
66 (16.7) |
|
Number of Patients
treated Unilaterally |
328 (83.2) |
|
Age
(years),
mean±SD |
57.6±9.8* |
|
Weight
(kg),
mean±SD |
70.7±11.5 |
|
Height
(cm),
mean±SD |
160.1±8.8 |
|
BMI
(kg/m2),
mean±SD Normal
(18.5–24.9)
Overweight (25–30) Obese (≥ 30.1) |
27.7±4.5 106 (26.9) 199 (50.6) 88 (22.5) |
|
Gender Male Female |
109 (27.7) 285 (72.3) |
|
Time
since
OA
diagnosis,
months
(years), mean±SD |
1.4±2.8 |
|
Target
Knee |
n
(%) |
|
Right
Knee |
220 (55.8) |
|
Left Knee |
174 (44.2) |
|
Prior
treatment/medications
for
target knee,
repetition |
203
(51.5) |
|
Anteroposterior and
Lateral (OR) Anteroposterior and Skyline in target knee |
394
(100) |
|
Femoro-patellar at
30°, repetition |
352 (89.3) |
|
Kellgren-Lawrence
grade
in
tibio-femoral
compartment
of the target
knee |
n (%) |
|
Grade
1 |
20 (5.1) |
|
Grade
2 |
151 (38.3) |
|
Grade
3** |
223 (56.6) |
|
Anaesthetics
used
in target
knee
(prior to the injection) |
n (%) |
|
Topical |
20 (5.1) |
|
Local |
127 (32.2) |
|
Approach used for injection |
n (%) |
|
Anterolateral |
1 (0.3) |
|
Superolateral |
160 (40.6) |
|
Superomedial |
116 (29.4) |
|
Inferolateral |
78 (19.8) |
|
Inferomedial |
39 (9.9) |
|
Medical and Surgical History |
n (%) |
|
Cardiovascular diseases Musculoskeletal disorders Metabolic/endocrine/nutritional
disorders |
98 (43.6) 79 (35.1) 77 (34.2) |
* N for age is 392 as age was missing for 2 patients.
** 1 patient with grade 4 OA was included with the grade 3 patient group.